RWA
CLVS

Ropes Wealth Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Ropes Wealth Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,956
Closed -$9K – 853
2020
Q4 		$9K Hold
1,956
– – ﹤0.01% 550
2020
Q3 		$11K Buy
+1,956
New +$11.7K ﹤0.01% 511
2019
Q3 		– Sell
-1,800
Closed -$27K – 599
2019
Q2 		$27K Buy
+1,800
New +$32.5K 0.01% 404

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ropes Wealth Advisors's CLVS Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 1,956 shares — an estimated $9K sold.

Ropes Wealth Advisors first reported a position in CLVS in Q2 2019 and held it in 3 quarters. The position peaked at $27K in Q2 2019. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

  • Ropes Wealth Advisors reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ropes Wealth Advisors sold 1,956 Clovis Oncology, Inc. shares in Q1 2021, an estimated $9K.
  • Ropes Wealth Advisors first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 3 quarters.
  • Ropes Wealth Advisors's Clovis Oncology, Inc. position peaked at $27K in Q2 2019.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.